N Engl J Med[Jour]AND 382 [volume] AND 1[issue]
新英格蘭醫學雜誌 382卷1期
1.
VenousThrombosis during Spaceflight.
太空飛行時靜脈血栓形成。
Auñón-ChancellorSM, Pattarini JM, Moll S, Sargsyan A.
N EnglJ Med. 2020 Jan 2;382(1):89-90.
2.
ACRISPR Path to Cutting-Edge Materials.
一條通向尖端材料的更清晰的道路。
ChenM, Luo D.
N EnglJ Med. 2020 Jan 2;382(1):85-88.
3.
ASober Reality? Alcohol, Abstinence, and Atrial Fibrillation.
清醒的現實？酒精、禁慾和房顫。
GillisAM.
N EnglJ Med. 2020 Jan 2;382(1):83-84.
4.
Whenthe Cause Is Not Crystal Clear.
當原因不明時。
ForryanJ, Mishra V, Gibbons E.
N EnglJ Med. 2020 Jan 2;382(1):74-78.
5.
Crepitusand Subcutaneous Emphysema.
腦瘤和皮下氣腫。
SalehY, Alratroot A.
N EnglJ Med. 2020 Jan 2;382(1):e1.
6.
FallopianTube Torsion.
輸卵管扭轉。
LimLM, Lin HZ.
N EnglJ Med. 2020 Jan 2;382(1):73.
7.
Headand Neck Cancer.
頭頸癌。
ChowLQM.
N EnglJ Med. 2020 Jan 2;382(1):60-72.
8.
Changesin Quality of Care after Hospital Mergers and Acquisitions.
醫院併購後護理質量的變化。
BeaulieuND, Dafny LS, Landon BE, Dalton JB, Kuye I, McWilliams JM.
N EnglJ Med. 2020 Jan 2;382(1):51-59.
9.
MultiyearFollow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
AAV5-hFVIII-SQ基因治療血友病A的多年隨訪。
PasiKJ, Rangarajan S, Mitchell N, Lester W, Symington E, Madan B, Laffan M, RussellCB, Li M, Pierce GF, Wong WY.
N EnglJ Med. 2020 Jan 2;382(1):29-40.
10.
AlcoholAbstinence in Drinkers with Atrial Fibrillation.
房顫飲酒者的酒精戒斷。
VoskoboinikA, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S, Prabhu S, StubD, Azzopardi S, Vizi D, Wong G, Nalliah C, Sugumar H, Wong M, Kotschet E, KayeD, Taylor AJ, Kistler PM.
N EnglJ Med. 2020 Jan 2;382(1):20-28.
11.
ReportingAdverse Events for Cannabis to the FDA.
向FDA報告大麻的不良事件。
HinesMC, Harinstein LM, Kortepeter CM.
N EnglJ Med. 2020 Jan 2;382(1):98.
12.
EpidemiologicSignatures in Cancer. Reply.
癌症的流行病學特徵。回復。
WelchHG, Kramer BS, Black WC.
N EnglJ Med. 2020 Jan 2;382(1):96-98.
13.
EpidemiologicSignatures in Cancer.
癌症的流行病學特徵。
CorcosD, Bleyer A.
N EnglJ Med. 2020 Jan 2;382(1):96.
14.
EpidemiologicSignatures in Cancer.
癌症的流行病學特徵。
JatoiI, Benson JR.
N EnglJ Med. 2020 Jan 2;382(1):95-96.
15.
Polypillfor Cardiovascular Disease Prevention in an Underserved Population. Reply.
在服務不足的人群中預防心血管疾病的息肉病。回復。
WangTJ, Muñoz D, Blot WJ.
N EnglJ Med. 2020 Jan 2;382(1):95.
16.
Polypillfor Cardiovascular Disease Prevention in an Underserved Population.
在服務不足的人群中預防心血管疾病的息肉病。
BilalU, Cainzos-Achirica M.
N EnglJ Med. 2020 Jan 2;382(1):94-95.
17.
Polypillfor Cardiovascular Disease Prevention in an Underserved Population.
在服務不足的人群中預防心血管疾病的息肉病。
BrugtsJJ.
N EnglJ Med. 2020 Jan 2;382(1):94.
18.
Vedolizumabversus Adalimumab for Moderate-to-Severe Ulcerative Colitis. Reply.
韋多留單抗與阿達木單抗治療中重度潰瘍性結腸炎的比較。回復。
SandsBE, Schreiber S, Lirio RA.
N EnglJ Med. 2020 Jan 2;382(1):93-94.
19.
Vedolizumabversus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
韋多留單抗與阿達木單抗治療中重度潰瘍性結腸炎的比較。
O'ConnorDB, Lahiff C.
N EnglJ Med. 2020 Jan 2;382(1):92-93.
20.
Vedolizumabversus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
韋多留單抗與阿達木單抗治療中重度潰瘍性結腸炎的比較。
BiemansVBC, Hoentjen F, Pierik MJ.
N EnglJ Med. 2020 Jan 2;382(1):92.
21.
Ustekinumabas Induction and Maintenance Therapy for Ulcerative Colitis. Reply.
烏司他單抗作為潰瘍性結腸炎的誘導和維持治療。回復。
SandsBE, Marano C.
N EnglJ Med. 2020 Jan 2;382(1):91.
22.
Ustekinumabas Induction and Maintenance Therapy for Ulcerative Colitis.
烏司他單抗作為潰瘍性結腸炎的誘導和維持治療。
RowanCR, Boland K, Harewood GC.
N EnglJ Med. 2020 Jan 2;382(1):91.
23.
ThePerformance Art of Student Doctoring.
醫學生的表演藝術。
WackerbarthJ.
N EnglJ Med. 2020 Jan 2;382(1):6-7.
24.
NEJMCatalyst Innovations in Care Delivery - A New Journal Leading theTransformation of Health Care Delivery.
NEJM促進醫療服務創新-引領醫療服務轉型的新雜誌。
LeeTH, Mohta NS, Prewitt E, Campion EW, Morrissey S, Drazen JM, Rubin EJ.
N EnglJ Med. 2020 Jan 2;382(1):80-81.
25.
DoubleEnvironmental Injustice - Climate Change, Hurricane Dorian, and the Bahamas.
雙重環境不公——氣候變化、多裡安颶風和巴哈馬。
ShultzJM, Sands DE, Kossin JP, Galea S.
N EnglJ Med. 2020 Jan 2;382(1):1-3.
26.
TowardHealthy Drug Policy in the United States - The Case of Safehouse.
美國的健康藥物政策——以安全屋為例。
BurrisS, Anderson ED, Davis CS, Beletsky L.
N EnglJ Med. 2020 Jan 2;382(1):4-5.
27.
OverallSurvival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
在未經治療的、EGFR突變的晚期NSCLC中，奧西米替尼的總生存率。
RamalingamSS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C,Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P,Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M,Rukazenkov Y, Soria JC; FLAURA Investigators.
N EnglJ Med. 2020 Jan 2;382(1):41-50.
28.
AComparison of Two LDL Cholesterol Targets after Ischemic Stroke.
缺血性卒中後兩種低密度脂蛋白膽固醇靶點的比較。
AmarencoP, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, DucrocqG, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallée PC, Lee BC, LeeKB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I,Steg PG, Sung SM, Touboul PJ, Touzé E, Varenne O, Vicaut É, Yelles N, BruckertE; Treat Stroke to Target Investigators.
N EnglJ Med. 2020 Jan 2;382(1):9.
29.
Statinsand Stroke - It's Complicated.
他汀類藥物和中風-很複雜。
WechslerLR.
N EnglJ Med. 2020 Jan 2;382(1):81-82.
N Engl J Med[Jour]AND 382 [volume] AND 2[issue]
新英格蘭醫學雜誌 382卷2期
1.
Progressin the Treatment of Breast Cancer. Reply.
乳腺癌治療進展。回復。
HayesDF.
N EnglJ Med. 2020 Jan 9;382(2):e4.
2.
Progressin the Treatment of Breast Cancer.
乳腺癌治療進展。
KonnerM.
N EnglJ Med. 2020 Jan 9;382(2):e4.
3.
ZikaVirus Infection - After the Pandemic. Reply.
寨卡病毒感染-大流行後。回復。
MussoD, Ko AI, Baud D.
N EnglJ Med. 2020 Jan 9;382(2):e3.
4.
ZikaVirus Infection - After the Pandemic.
寨卡病毒感染-大流行後。
PachecoLD, Weaver SC, Saade GR.
N EnglJ Med. 2020 Jan 9;382(2):e3.
5.
InhaledGM-CSF for Pulmonary Alveolar Proteinosis. Reply.
吸入GM-CSF治療肺泡蛋白沉積症。回復。
TazawaR, Kitamura N, Nakata K.
N EnglJ Med. 2020 Jan 9;382(2):198.
6.
InhaledGM-CSF for Pulmonary Alveolar Proteinosis.
吸入GM-CSF治療肺泡蛋白沉積症。
PapirisSA, Griese M, Manali ED.
N EnglJ Med. 2020 Jan 9;382(2):197.
7.
Detectionof Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient.
HIV陽性腎移植受者中供者HIV株的檢測。
BlasiM, Stadtler H, Chang J, Hemmersbach-Miller M, Wyatt C, Klotman P, Gao F, WolfeC, Klotman M.
N EnglJ Med. 2020 Jan 9;382(2):195-197.
8.
Treatmentafter TAVR - Discordance and Clinical Implications.
TAVR後的治療-不一致性和臨床意義。
NishimuraRA, Holmes DR Jr.
N EnglJ Med. 2020 Jan 9;382(2):193-194.
9.
Case1-2020: An 11-Year-Old Boy with Vomiting and Weight Loss.
病例1-2020：一名11歲男孩嘔吐和體重減輕。
FasanoA, Leonard MM, Mitchell DM, Eng G.
N EnglJ Med. 2020 Jan 9;382(2):180-189.
10.
CutaneousLeishmaniasis.
皮膚利什曼病。
KnappAP, Alpern JD.
N EnglJ Med. 2020 Jan 9;382(2):e2.
11.
AxillaryArtery Occlusion after TAVR.
TAVR後腋窩動脈閉塞
KilleA, Hochholzer W.
N EnglJ Med. 2020 Jan 9;382(2):179.
12.
BaroreflexDysfunction.
壓力反射功能障礙。
KaufmannH, Norcliffe-Kaufmann L, Palma JA.
N EnglJ Med. 2020 Jan 9;382(2):163-178.
13.
HealthCare Hotspotting - A Randomized, Controlled Trial.
醫療保健熱點-一項隨機對照試驗。
FinkelsteinA, Zhou A, Taubman S, Doyle J.
N EnglJ Med. 2020 Jan 9;382(2):152-162.
14.
Luspaterceptin Patients with Lower-Risk Myelodysplastic Syndromes.
結論低風險骨髓增生異常症候群患者的治療。
FenauxP, Platzbecker U, Mufti GJ, Garcia-Manero G, Buckstein R, Santini V,Díez-Campelo M, Finelli C, Cazzola M, Ilhan O, Sekeres MA, Falantes JF,Arrizabalaga B, Salvi F, Giai V, Vyas P, Bowen D, Selleslag D, DeZern AE,Jurcic JG, Germing U, Götze KS, Quesnel B, Beyne-Rauzy O, Cluzeau T, Voso MT,Mazure D, Vellenga E, Greenberg PL, Hellström-Lindberg E, Zeidan AM, Adès L,Verma A, Savona MR, Laadem A, Benzohra A, Zhang J, Rampersad A, Dunshee DR,Linde PG, Sherman ML, Komrokji RS, List AF.
N EnglJ Med. 2020 Jan 9;382(2):140-151.
15.
ThePatient-Scientist's Mandate.
病人科學家的任務。
VallabhSM.
N EnglJ Med. 2020 Jan 9;382(2):107-109.
16.
Costs,Benefits, and Sacred Values - Why Health Care Reform Is So Fraught.
成本、利益和神聖的價值觀——為什麼醫療改革如此令人擔憂。
RosenbaumL.
N EnglJ Med. 2020 Jan 9;382(2):101-104.
17.
TheFalse Promise of Natural Gas.
天然氣的虛假承諾。
LandriganPJ, Frumkin H, Lundberg BE.
N EnglJ Med. 2020 Jan 9;382(2):104-107.
18.
ReducedLeaflet Motion after Transcatheter Aortic-Valve Replacement.
經導管主動脈瓣置換術後小葉運動減少。
DeBacker O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, Kini AS,Veien KT, Abdel-Wahab M, Kim WK, Balan P, Van Mieghem N, Mathiassen ON, JegerRV, Arnold M, Mehran R, Guimarães AHC, Nørgaard BL, Kofoed KF, Blanke P,Windecker S, Søndergaard L; GALILEO-4D Investigators.
N EnglJ Med. 2020 Jan 9;382(2):130-139.
19.
EarlySurgery or Conservative Care for Asymptomatic Aortic Stenosis.
無症狀主動脈狹窄的早期手術或保守治療。
KangDH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, Yun SC, Hong GR, Song JM, Chung CH,Song JK, Lee JW, Park SW.
N EnglJ Med. 2020 Jan 9;382(2):111-119.
20.
AControlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
利伐沙班經導管主動脈瓣置換術後的對照試驗。
DangasGD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR,Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L,Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D,Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, ZazulaA, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators.
N EnglJ Med. 2020 Jan 9;382(2):120-129.
21.
Timingof Intervention in Aortic Stenosis.
主動脈狹窄介入治療的時機。
LancellottiP, Vannan MA.
N EnglJ Med. 2020 Jan 9;382(2):191-193.
N Engl J Med[Jour]AND 382 [volume] AND 3[issue]
新英格蘭醫學雜誌 382卷3期
1.
Effectsof Intermittent Fasting on Health, Aging, and Disease.
間歇性禁食對健康、衰老和疾病的影響。
[Noauthors listed]
N EnglJ Med. 2020 Jan 16;382(3):298.
2.
Medicalversus Surgical Treatment for Refractory Heartburn. Reply.
難治性胃灼熱的內科與外科治療。回復。
SpechlerSJ.
N EnglJ Med. 2020 Jan 16;382(3):297-298.
3.
Medicalversus Surgical Treatment for Refractory Heartburn.
難治性胃灼熱的內科與外科治療。
GardnerRC.
N EnglJ Med. 2020 Jan 16;382(3):297.
4.
Medicalversus Surgical Treatment for Refractory Heartburn.
難治性胃灼熱的內科與外科治療。
NicolaidesS, Apostolov R, Vasudevan A.
N EnglJ Med. 2020 Jan 16;382(3):297.
5.
Medicalversus Surgical Treatment for Refractory Heartburn.
難治性胃灼熱的內科與外科治療。
YadlapatiR, Pandolfino JE.
N EnglJ Med. 2020 Jan 16;382(3):296-297.
6.
ExtracorporealPhotopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy.
體外光球治療由檢查點抑制劑引起的結腸炎。
ApostolovaP, Unger S, von Bubnoff D, Meiss F, Becher B, Zeiser R.
N EnglJ Med. 2020 Jan 16;382(3):294-296.
7.
Cytokinesis,Beta-Blockers, and Congenital Heart Disease.
胞質分裂、β受體阻滯劑和先天性心臟病。
YutzeyKE.
N EnglJ Med. 2020 Jan 16;382(3):291-293.
8.
Difelikefalinfor the Treatment of Uremic Pruritus.
地非利克法林治療尿毒症瘙癢。
SteeleDJR.
N EnglJ Med. 2020 Jan 16;382(3):289-290.
9.
Case2-2020: A 64-Year-Old Man with Fever and Respiratory Failure.
病例2-2020：一名64歲男子，患有發燒和呼吸衰竭。
AzarMM, Muse VV, Villalba JA, Turbett SE.
N EnglJ Med. 2020 Jan 16;382(3):276-285.
10.
SkinDiscoloration from Amiodarone.
胺碘酮引起皮膚變色。
MurphyRP, Canavan M.
N EnglJ Med. 2020 Jan 16;382(3):e5.
11.
CrazyPaving in Pulmonary Alveolar Proteinosis.
肺泡蛋白沉積症的瘋狂鋪砌。
AllwoodBW, Bennji S.
N EnglJ Med. 2020 Jan 16;382(3):275.
12.
Suicide.
自殺。
FazelS, Runeson B.
N EnglJ Med. 2020 Jan 16;382(3):266-274.
13.
JAKInhibitor Therapy in a Child with Inherited USP18 Deficiency.
JAK抑制劑治療兒童遺傳性USP18缺乏症。
AlsohimeF, Martin-Fernandez M, Temsah MH, Alabdulhafid M, Le Voyer T, Alghamdi M, QiuX, Alotaibi N, Alkahtani A, Buta S, Jouanguy E, Al-Eyadhy A, Gruber C, HasanGM, Bashiri FA, Halwani R, Hassan HH, Al-Muhsen S, Alkhamis N, Alsum Z,Casanova JL, Bustamante J, Bogunovic D, Alangari AA.
N EnglJ Med. 2020 Jan 16;382(3):256-265.
14.
ARandomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
促紅細胞生成素對早產兒神經保護的隨機試驗。
JuulSE, Comstock BA, Wadhawan R, Mayock DE, Courtney SE, Robinson T, Ahmad KA,Bendel-Stenzel E, Baserga M, LaGamma EF, Downey LC, Rao R, Fahim N, Lampland A,Frantz Iii ID, Khan JY, Weiss M, Gilmore MM, Ohls RK, Srinivasan N, Perez JE,McKay V, Vu PT, Lowe J, Kuban K, O'Shea TM, Hartman AL, Heagerty PJ; PENUTTrial Consortium.
N EnglJ Med. 2020 Jan 16;382(3):233-243.
15.
TreatingAddiction as a Terminal Disease.
把上癮當作絕症。
CarusoBrown AE.
N EnglJ Med. 2020 Jan 16;382(3):207-209.
16.
DialogicPraxis - A 16-Year-Old Boy with Anxiety in Southern Brazil.
對話-實踐-一個16歲的男孩在巴西南部焦慮。
BéhagueDP, Frankfurter RG, Hansen H, Victora CG.
N EnglJ Med. 2020 Jan 16;382(3):201-204.
17.
Lipoprotein(a)Reduction in Persons with Cardiovascular Disease.
脂蛋白（a）在心血管疾病患者中的降低。
TsimikasS, Karwatowska-Prokopczuk E, Gouni-Berthold I, Tardif JC, Baum SJ,Steinhagen-Thiessen E, Shapiro MD, Stroes ES, Moriarty PM, Nordestgaard BG, XiaS, Guerriero J, Viney NJ, O'Dea L, Witztum JL; AKCEA-APO(a)-LRx StudyInvestigators.
N EnglJ Med. 2020 Jan 16;382(3):244-255.
18.
ASuccessful Trial for Lupus - How Good Is Good Enough?
一個成功的狼瘡試驗-有多好足夠好？
SalmonJE, Niewold TB.
N EnglJ Med. 2020 Jan 16;382(3):287-288.
19.
Trialof Anifrolumab in Active Systemic Lupus Erythematosus.
安非洛單抗治療活動期系統性紅斑狼瘡的臨床研究。
MorandEF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ,Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators.
N EnglJ Med. 2020 Jan 16;382(3):211-221.
20.
Soundingthe Alarm on Climate Change, 1989 and 2019.
為1989年和2019年的氣候變化敲響警鐘。
DunkJH, Jones DS.
N EnglJ Med. 2020 Jan 16;382(3):205-207.
21.
APhase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
Difelikefalin治療血液透析患者瘙癢的3期試驗。
FishbaneS, Jamal A, Munera C, Wen W, Menzaghi F; KALM-1 Trial Investigators.
N EnglJ Med. 2020 Jan 16;382(3):222-232.
N Engl J Med[Jour]AND 382 [volume] AND 4[issue]
新英格蘭醫學雜誌 382卷4期
1.
TheCost of Applying to Medical School. Reply.
申請醫學院的費用。回復。
MilloL, Ho N, Ubel PA.
N EnglJ Med. 2020 Jan 23;382(4):e8.
2.
TheCost of Applying to Medical School.
申請醫學院的費用。
EssienUR, Howard D, Ibrahim S.
N EnglJ Med. 2020 Jan 23;382(4):e8.
3.
TheCost of Applying to Medical School.
申請醫學院的費用。
CampbellGV, Skorton DJ.
N EnglJ Med. 2020 Jan 23;382(4):e8.
4.
Frameworkfor "N-of-1" Experimental Therapies.
「N/1」實驗療法的框架。
BrierleyJ, Aylett S, Archard D.
N EnglJ Med. 2020 Jan 23;382(4):e7.
5.
HereditaryThrombotic Thrombocytopenic Purpura. Reply.
遺傳性血小板減少性紫癜。回復。
KremerHovinga JA, George JN.
N EnglJ Med. 2020 Jan 23;382(4):394-395.
6.
HereditaryThrombotic Thrombocytopenic Purpura.
遺傳性血小板減少性紫癜。
DelmasY, Renou P, Sibon I.
N EnglJ Med. 2020 Jan 23;382(4):393-394.
7.
HereditaryThrombotic Thrombocytopenic Purpura.
遺傳性血小板減少性紫癜。
HamrounA, Prouteau C, Provôt F.
N EnglJ Med. 2020 Jan 23;382(4):392-393.
8.
Step-UpTherapy in Black Patients with Asthma. Reply.
加強對黑人哮喘患者的治療。回復。
WechslerME, Ortega VE, Israel E; NHLBI AsthmaNet.
N EnglJ Med. 2020 Jan 23;382(4):391-392.
9.
Step-UpTherapy in Black Patients with Asthma.
加強對黑人哮喘患者的治療。
LipworthB, Chan R, Kuo CR.
N EnglJ Med. 2020 Jan 23;382(4):391.
10.
Step-UpTherapy in Black Patients with Asthma.
加強對黑人哮喘患者的治療。
MerckxJ, Kaufman JS, Cooper RS.
N EnglJ Med. 2020 Jan 23;382(4):390-391.
11.
Step-UpTherapy in Black Patients with Asthma.
加強對黑人哮喘患者的治療。
KeshS, Jones BL.
N EnglJ Med. 2020 Jan 23;382(4):390.
12.
Heat-InducedBrain Vitrification from the Vesuvius Eruption in c.e. 79.
公元前79年維蘇威火山噴發引起的熱致腦玻璃化。
PetroneP, Pucci P, Niola M, Baxter PJ, Fontanarosa C, Giordano G, Graziano V, SiranoF, Amoresano A.
N EnglJ Med. 2020 Jan 23;382(4):383-384.
13.
Choosinga Mass Immunization Program against Meningococcal B.
選擇腦膜炎球菌B群免疫方案。
Wu K,Mulholland EK, Edwards KM.
N EnglJ Med. 2020 Jan 23;382(4):379-382.
14.
GoodNews and Bad News - 4CMenB Vaccine for Group B Neisseria meningitidis.
好消息和壞消息-B組腦膜炎奈瑟菌4CMenB疫苗。
HarrisonLH, Stephens DS.
N EnglJ Med. 2020 Jan 23;382(4):376-378.
15.
Case3-2020: A 44-Year-Old Man with Weight Loss, Diarrhea, and Abdominal Pain.
病例3-2020：44歲男性，體重減輕，腹瀉，腹痛。
LoweRC, Chu JN, Pierce TT, Weil AA, Branda JA.
N EnglJ Med. 2020 Jan 23;382(4):365-374.
16.
Fluorouracil-InducedHyperpigmentation.
氟尿嘧啶引起的色素沉著。
SchaeferJK, Ramnath N.
N EnglJ Med. 2020 Jan 23;382(4):e6.
17.
IntrahepaticBiliary Ductal Dilatation.
肝內膽管擴張。
RossiUG, Cariati M.
N EnglJ Med. 2020 Jan 23;382(4):364.
18.
TreatingHypertension in Chronic Obstructive Pulmonary Disease.
慢性阻塞性肺疾病高血壓的治療。
FinksSW, Rumbak MJ, Self TH.
N EnglJ Med. 2020 Jan 23;382(4):353-363.
19.
Teprotumumabfor the Treatment of Active Thyroid Eye Disease.
鐵皮瘤單抗治療活動性甲狀腺眼病。
DouglasRS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT,Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, SchiffmanJ, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, SmithTJ.
N EnglJ Med. 2020 Jan 23;382(4):341-352.
20.
Elagolixfor Heavy Menstrual Bleeding in Women with Uterine Fibroids.
依拉哥利克斯治療子宮肌瘤患者月經大出血。
SchlaffWD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR,Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG Jr, Owens CD, Poindexter A,Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB,Muneyyirci-Delale O.
N EnglJ Med. 2020 Jan 23;382(4):328-340.
21.
MeningococcalB Vaccine and Meningococcal Carriage in Adolescents in Australia.
澳大利亞青少年中的腦膜炎球菌B疫苗和腦膜炎球菌攜帶。
MarshallHS, McMillan M, Koehler AP, Lawrence A, Sullivan TR, MacLennan JM, Maiden MCJ,Ladhani SN, Ramsay ME, Trotter C, Borrow R, Finn A, Kahler CM, Whelan J,Vadivelu K, Richmond P.
N EnglJ Med. 2020 Jan 23;382(4):318-327.
22.
Vaccinationof Infants with Meningococcal Group B Vaccine (4CMenB) in England.
英國嬰兒接種B群腦膜炎球菌疫苗（4CMenB）。
LadhaniSN, Andrews N, Parikh SR, Campbell H, White J, Edelstein M, Bai X, Lucidarme J,Borrow R, Ramsay ME.
N EnglJ Med. 2020 Jan 23;382(4):309-317.
23.
Healingas a Servant Instead of a Prophet.
作為僕人而不是先知來治療。
Lee MJr.
N EnglJ Med. 2020 Jan 23;382(4):306-307.
24.
Paymentfor Services Rendered - Updating Medicare's Valuation of Procedures.
提供服務的付款-更新醫療保險程序的估價。
MulcahyAW, Merrell K, Mehrotra A.
N EnglJ Med. 2020 Jan 23;382(4):303-306.
25.
AdvancingSafety and Equity Together.
共同推進安全與公平。
SivashankerK, Gandhi TK.
N EnglJ Med. 2020 Jan 23;382(4):301-303.
26.
Moreon the Pathology of Vaping-Associated Lung Injury. Reply.
更多關於呼氣相關性肺損傷的病理學研究。回復。
LarsenBT, Butt YM, Smith ML.
N EnglJ Med. 2020 Jan 23;382(4):388-390.
27.
Moreon the Pathology of Vaping-Associated Lung Injury.
更多關於呼氣相關性肺損傷的病理學研究。
DavidsonKR, Fox DL.
N EnglJ Med. 2020 Jan 23;382(4):388.
28.
Moreon the Pathology of Vaping-Associated Lung Injury.
更多關於呼氣相關性肺損傷的病理學研究。
MarsdenL, Michalicek ZD, Christensen ED.
N EnglJ Med. 2020 Jan 23;382(4):387-388.
29.
PulmonaryIllness Related to E-Cigarette Use. Reply.
與電子菸使用有關的肺部疾病。回復。
LaydenJE, King BA, Meiman J.
N EnglJ Med. 2020 Jan 23;382(4):386.
30.
PulmonaryIllness Related to E-Cigarette Use.
與電子菸使用有關的肺部疾病。
RussellCD, Cevik M.
N EnglJ Med. 2020 Jan 23;382(4):385-386.
31.
PulmonaryIllness Related to E-Cigarette Use.
與電子菸使用有關的肺部疾病。
DiazCD, Carroll BJ, Hemyari A.
N EnglJ Med. 2020 Jan 23;382(4):384-385.
N Engl J Med[Jour]AND 382 [volume] AND 5[issue]
新英格蘭醫學雜誌 382卷5期
1.
Identificationfrom MRI with Face-Recognition Software. Reply.
利用人臉識別軟體進行MRI圖像識別。回復。
SchwarzCG, Petersen RC, Jack CR Jr.
N EnglJ Med. 2020 Jan 30;382(5):490.
2.
Identificationfrom MRI with Face-Recognition Software.
利用人臉識別軟體進行MRI圖像識別。
JuluruK, Siegel E, Mazura J.
N EnglJ Med. 2020 Jan 30;382(5):489-490.
3.
Statinsfor Familial Hypercholesterolemia from Childhood. Reply.
他汀類藥物治療兒童家族性高膽固醇血症。回復。
LuirinkIK, Kusters DM, Hutten BA.
N EnglJ Med. 2020 Jan 30;382(5):488-489.
4.
Statinsfor Familial Hypercholesterolemia from Childhood.
他汀類藥物治療兒童家族性高膽固醇血症。
MurataY, Kami M.
N EnglJ Med. 2020 Jan 30;382(5):488.
5.
Statinsfor Familial Hypercholesterolemia from Childhood.
他汀類藥物治療兒童家族性高膽固醇血症。
BijlD, Hama R.
N EnglJ Med. 2020 Jan 30;382(5):487-488.
6.
Ticagreloror Prasugrel in Acute Coronary Syndromes. Reply.
替卡格雷或普拉格雷治療急性冠狀動脈症候群。回復。
SchüpkeS, Kastrati A.
N EnglJ Med. 2020 Jan 30;382(5):487.
7.
Ticagreloror Prasugrel in Acute Coronary Syndromes.
替卡格雷或普拉格雷治療急性冠狀動脈症候群。
SharmaS, Lardizabal J, Sharma R.
N EnglJ Med. 2020 Jan 30;382(5):487.
8.
Ticagreloror Prasugrel in Acute Coronary Syndromes.
替卡格雷或普拉格雷治療急性冠狀動脈症候群。
Carbonell-PratB, Flores-Umanzor E, Brugaletta S.
N EnglJ Med. 2020 Jan 30;382(5):486.
9.
Longer-TermOutcomes of the ProACT Trial.
ProACT試驗的長期結果。
HuangDT, Yealy DM, Angus DC; ProACT Investigators.
N EnglJ Med. 2020 Jan 30;382(5):485-486.
10.
PrimeTime for Genome Editing?
基因組編輯的黃金時間？
UrnovFD.
N EnglJ Med. 2020 Jan 30;382(5):481-484.
11.
Understandingthe Rewards of Successful Drug Development - Thinking Inside the Box.
了解成功藥物開發的回報-在盒子裡思考。
KhullarD, Ohn JA, Trusheim M, Bach PB.
N EnglJ Med. 2020 Jan 30;382(5):473-480.
12.
RiskPrediction for Acute Kidney Injury - Super Important, Now suPAR Easy?
急性腎損傷的風險預測-非常重要，現在SUPAR容易嗎？
TackeF.
N EnglJ Med. 2020 Jan 30;382(5):470-472.
13.
Clearingthe Air - A Conservative Option for Spontaneous Pneumothorax.
清除空氣-自發性氣胸的保守選擇。
BroaddusVC.
N EnglJ Med. 2020 Jan 30;382(5):469-470.
14.
Case4-2020: A 52-Year-Old Woman with Seizure Disorder and Wide-Complex Tachycardia.
病例4-2020：一名52歲女性，患有癲癇發作和廣泛的複雜心動過速。
KramerDB, Mihatov N, Buch KA, Zafar SF, Ruskin JN.
N EnglJ Med. 2020 Jan 30;382(5):457-467.
15.
ARapid Change in Pressure.
壓力的迅速變化。
D'SilvaK, Vaidya A, Smithy JW, Anderson WJ, Cockrill B.
N EnglJ Med. 2020 Jan 30;382(5):e8.
16.
GastrointestinalBleeding from Metastatic Melanoma.
轉移性黑色素瘤引起的胃腸道出血。
LimAHW, Argyrides J.
N EnglJ Med. 2020 Jan 30;382(5):e7.
17.
HarlequinColor Change in a Neonate.
新生兒的丑角顏色變化。
vanden Berg G, Bakker H.
N EnglJ Med. 2020 Jan 30;382(5):456.
18.
HormoneTherapy for Postmenopausal Women.
絕經後婦女的激素治療。
PinkertonJV.
N EnglJ Med. 2020 Jan 30;382(5):446-455.
19.
FatalCytomegalovirus Infection in an Adult with Inherited NOS2 Deficiency.
遺傳性NOS2缺乏症成人的致命巨細胞病毒感染。
DrutmanSB, Mansouri D, Mahdaviani SA, Neehus AL, Hum D, Bryk R, Hernandez N, BelkayaS, Rapaport F, Bigio B, Fisch R, Rahman M, Khan T, Al Ali F, Marjani M,Mansouri N, Lorenzo-Diaz L, Emile JF, Marr N, Jouanguy E, Bustamante J, Abel L,Boisson-Dupuis S, Béziat V, Nathan C, Casanova JL.
N EnglJ Med. 2020 Jan 30;382(5):437-445.
20.
FamilyHistory of Gastric Cancer and Helicobacter pylori Treatment.
胃癌家族史與幽門螺桿菌治療。
ChoiIJ, Kim CG, Lee JY, Kim YI, Kook MC, Park B, Joo J.
N EnglJ Med. 2020 Jan 30;382(5):427-436.
21.
SolubleUrokinase Receptor and Acute Kidney Injury.
可溶性尿激酶受體與急性腎損傷。
HayekSS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, Sever S, Camacho A,Wang X, Dande RR, Ibrahim NE, Baron RM, Altintas MM, Wei C, Sheikh-Hamad D, PanJS, Holliday MW Jr, Januzzi JL, Weisbord SD, Quyyumi AA, Reiser J.
N EnglJ Med. 2020 Jan 30;382(5):416-426.
22.
Conservativeversus Interventional Treatment for Spontaneous Pneumothorax.
自發性氣胸的保守治療與介入治療。
BrownSGA, Ball EL, Perrin K, Asha SE, Braithwaite I, Egerton-Warburton D, Jones PG,Keijzers G, Kinnear FB, Kwan BCH, Lam KV, Lee YCG, Nowitz M, Read CA, SimpsonG, Smith JA, Summers QA, Weatherall M, Beasley R; PSP Investigators.
N EnglJ Med. 2020 Jan 30;382(5):405-415.
23.
Fun.
很有趣。
ColaianniCA.
N EnglJ Med. 2020 Jan 30;382(5):402-403.
24.
TheNeglected Hospital - The District Hospital's Central Role in Global Health CareDelivery.
被忽視的醫院-地區醫院在全球醫療服務中的中心作用。
RajbhandariR, McMahon DE, Rhatigan JJ, Farmer PE.
N EnglJ Med. 2020 Jan 30;382(5):397-400.
25.
IsObamacare Really Unconstitutional?
歐巴馬醫改真的違憲嗎？
BagleyN.
N EnglJ Med. 2020 Jan 30;382(5):400-401.
26.
Retraction:Retinal Hemorrhage from Blunt Ocular Trauma. N Engl J Med 2019;381:2252.
回縮：鈍性眼外傷引起的視網膜出血。英國醫學雜誌2019；381:2252。
JinagalJ, Dhiman P.
N EnglJ Med. 2019 Dec 23;382(5):490.
N Engl J Med[Jour]AND 382 [volume] AND 6[issue]
新英格蘭醫學雜誌 382卷6期
1．
AnAnti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
一種抗CD3抗體，特普利珠單抗，存在1型糖尿病風險的親屬。
[No authorslisted]
N EnglJ Med. 2020 Feb 6;382(6):586.
2.
Case33-2019: A Woman with Cardiopulmonary Arrest during Cesarean Section. Reply.
病例33-2019：一名剖宮產術中心肺驟停的婦女。回復。
OrtizVE, Dzik WH.
N EnglJ Med. 2020 Feb 6;382(6):585.
3.
Case33-2019: A Woman with Cardiopulmonary Arrest during Cesarean Section.
病例33-2019：一名剖宮產術中心肺驟停的婦女。
MorrisonC.
N EnglJ Med. 2020 Feb 6;382(6):584-585.
4.
Case33-2019: A Woman with Cardiopulmonary Arrest during Cesarean Section.
病例33-2019：一名剖宮產術中心肺驟停的婦女。
LemoineS, Jost D, Prunet B.
N EnglJ Med. 2020 Feb 6;382(6):584.
5.
Schizophrenia.
精神分裂症。
GoldmanML, Pincus HA, Mangurian C.
N EnglJ Med. 2020 Feb 6;382(6):583-584.
6.
Mistreatmentand Burnout in Surgical Residency Training. Reply.
外科住院醫師培訓中的虐待和倦怠。回復。
Hu YY,Ellis RJ, Bilimoria KY.
N EnglJ Med. 2020 Feb 6;382(6):582-583.
7.
Mistreatmentand Burnout in Surgical Residency Training.
外科住院醫師培訓中的虐待和倦怠。
UlrichCM.
N EnglJ Med. 2020 Feb 6;382(6):582.
8.
Mistreatmentand Burnout in Surgical Residency Training.
外科住院醫師培訓中的虐待和倦怠。
DavidEA, Stephens EH, Kane L.
N EnglJ Med. 2020 Feb 6;382(6):581-582.
9.
Mistreatmentand Burnout in Surgical Residency Training.
外科住院醫師培訓中的虐待和倦怠。
LaraméeJ.
N EnglJ Med. 2020 Feb 6;382(6):581.
10.
Ligelizumabfor Chronic Spontaneous Urticaria. Reply.
利格列珠單抗治療慢性自發性蕁麻疹。回復。
CenterDM.
N EnglJ Med. 2020 Feb 6;382(6):580.
11.
Ligelizumabfor Chronic Spontaneous Urticaria. Reply.
利格列珠單抗治療慢性自發性蕁麻疹。回復。
MaurerM, Giménez-Arnau AM, Metz M.
N EnglJ Med. 2020 Feb 6;382(6):579-580.
12.
Ligelizumabfor Chronic Spontaneous Urticaria.
利格列珠單抗治療慢性自發性蕁麻疹。
WeinbergerM.
N EnglJ Med. 2020 Feb 6;382(6):579.
13.
Ligelizumabfor Chronic Spontaneous Urticaria.
利格列珠單抗治療慢性自發性蕁麻疹。
CohenJM.
N EnglJ Med. 2020 Feb 6;382(6):579.
14.
MulticenterTrial of Closed-Loop Control in Type 1 Diabetes. Reply.
1型糖尿病閉環控制多中心試驗。回復。
KovatchevBP, Brown SA, Beck RW.
N EnglJ Med. 2020 Feb 6;382(6):578.
15.
MulticenterTrial of Closed-Loop Control in Type 1 Diabetes.
1型糖尿病閉環控制多中心試驗。
Zuñiga-HernandezJA, Medrano-De Avila C, Rodríguez-Gutiérrez R.
N EnglJ Med. 2020 Feb 6;382(6):577-578.
16.
MulticenterTrial of Closed-Loop Control in Type 1 Diabetes.
1型糖尿病閉環控制多中心試驗。
TakitaM.
N EnglJ Med. 2020 Feb 6;382(6):577.
17.
OrganDonation after Medical Assistance in Dying - Canada's First Cases.
臨終醫療救助後器官捐獻——加拿大首例。
BallIM, Healey A, Keenan S, Priestap F, Basmaji J, Honarmand K, Parsons Leigh J,Shemie S, Chaudhury P, Singh JM, Zaltzman J, Beed S, Weiss M.
N EnglJ Med. 2020 Feb 6;382(6):576-577.
18.
VitaminD Supplementation during Pregnancy and the Prevention of Childhood Asthma.
孕期補充維生素D與兒童哮喘的預防。
vonMutius E, Martinez FD.
N EnglJ Med. 2020 Feb 6;382(6):574-575.
19.
ARapid Change in Pressure.
壓力的迅速變化。
D'SilvaK, Cockrill B, Anderson WJ, Miller AL, Loscalzo J.
N EnglJ Med. 2020 Feb 6;382(6):563-570.
20.
TwinAnemia Polycythemia Sequence.
雙胎貧血紅細胞增多症序列。
AraújoPereira J, Sousa Gomes M.
N EnglJ Med. 2020 Feb 6;382(6):e9.
21.
ExtranodalNatural Killer T-Cell Lymphoma.
結外自然殺傷性T細胞淋巴瘤。
ChiKY, Shen HN.
N EnglJ Med. 2020 Feb 6;382(6):562.
22.
Placeboand Nocebo Effects.
安慰劑和Nocebo效應。
CollocaL, Barsky AJ.
N EnglJ Med. 2020 Feb 6;382(6):554-561.
23.
Use ofCAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
CAR轉導的自然殺傷細胞在CD19陽性淋巴腫瘤中的應用。
Liu E,Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L,Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, DaherM, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, WierdaW, Keating M, Champlin R, Shpall EJ, Rezvani K.
N EnglJ Med. 2020 Feb 6;382(6):545-553.
24.
Lowerversus Traditional Treatment Threshold for Neonatal Hypoglycemia.
新生兒低血糖症較傳統治療閾值低。
vanKempen AAMW, Eskes PF, Nuytemans DHGM, van der Lee JH, Dijksman LM, vanVeenendaal NR, van der Hulst FJPCM, Moonen RMJ, Zimmermann LJI, van 't VerlaatEP, van Dongen-van Baal M, Semmekrot BA, Stas HG, van Beek RHT, Vlietman JJ,Dijk PH, Termote JUM, de Jonge RCJ, de Mol AC, Huysman MWA, Kok JH, Offringa M,Boluyt N; HypoEXIT Study Group.
N EnglJ Med. 2020 Feb 6;382(6):534-544.
25.
Six-YearFollow-up of a Trial of Antenatal Vitamin D for Asthma Reduction.
產前維生素D治療哮喘6年隨訪。
LitonjuaAA, Carey VJ, Laranjo N, Stubbs BJ, Mirzakhani H, O'Connor GT, Sandel M,Beigelman A, Bacharier LB, Zeiger RS, Schatz M, Hollis BW, Weiss ST.
N EnglJ Med. 2020 Feb 6;382(6):525-533.
26.
JoiningForces against Delirium - From Organ-System Care to Whole-Human Care.
共同對抗精神錯亂-從器官系統護理到全人類護理。
InouyeSK.
N EnglJ Med. 2020 Feb 6;382(6):499-501.
27.
Altruismin Extremis - The Evolving Ethics of Organ Donation.
極端的利他主義——器官捐獻的倫理進化。
RosenbaumL.
N EnglJ Med. 2020 Feb 6;382(6):493-496.
28.
ReducedLung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
在一項隨機試驗中用容積CT篩查降低肺癌死亡率。
deKoning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, HeuvelmansMA, Lammers JJ, Weenink C, Yousaf-Khan U, Horeweg N, van 't Westeinde S, ProkopM, Mali WP, Mohamed Hoesein FAA, van Ooijen PMA, Aerts JGJV, den Bakker MA,Thunnissen E, Verschakelen J, Vliegenthart R, Walter JE, Ten Haaf K, Groen HJM,Oudkerk M.
N EnglJ Med. 2020 Feb 6;382(6):503-513.
29.
MortalityReduction with Low-Dose CT Screening for Lung Cancer.
肺癌低劑量CT篩查降低死亡率。
DuffySW, Field JK.
N EnglJ Med. 2020 Feb 6;382(6):572-573.
30.
Abusesof FDA Regulatory Procedures - The Case of Suboxone.
濫用FDA監管程序-以Suboxone為例。
HaffajeeRL, Frank RG.
N EnglJ Med. 2020 Feb 6;382(6):496-498.
31.
Tucatinib,Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Tucatinib、曲妥珠單抗和卡培他濱治療HER2陽性轉移性乳腺癌。
[Noauthors listed]
N EnglJ Med. 2020 Feb 6;382(6):586.
32.
OverallSurvival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
核糖體結合富維斯特治療晚期乳腺癌的總生存率。
SlamonDJ, Neven P, Chia S, Fasching PA, De Laurentiis M, Im SA, Petrakova K, BianchiGV, Esteva FJ, Martín M, Nusch A, Sonke GS, De la Cruz-Merino L, Beck JT, PivotX, Sondhi M, Wang Y, Chakravartty A, Rodriguez-Lorenc K, Taran T, Jerusalem G.
N EnglJ Med. 2020 Feb 6;382(6):514-524.
N Engl J Med[Jour]AND 382 [volume] AND 7[issue]
新英格蘭醫學雜誌 382卷7期
1．
AcuteSevere Hypertension. Reply.
急性重度高血壓。回復。
PeixotoAJ.
N EnglJ Med. 2020 Feb 13;382(7):e11.
2.
AcuteSevere Hypertension.
急性重度高血壓。
ParmarMS.
N EnglJ Med. 2020 Feb 13;382(7):e11.
3.
AcuteSevere Hypertension.
急性重度高血壓。
RubinS, Combe C, Gosse P.
N EnglJ Med. 2020 Feb 13;382(7):e11.
4.
AcuteSevere Hypertension.
急性重度高血壓。
SibleyA, Shayne P.
N EnglJ Med. 2020 Feb 13;382(7):e11.
5.
SecondarySurgical Cytoreduction for Recurrent Ovarian Cancer. Reply.
復發性卵巢癌的二期手術細胞減少術。回復。
ColemanRL.
N EnglJ Med. 2020 Feb 13;382(7):686.
6.
SecondarySurgical Cytoreduction for Recurrent Ovarian Cancer.
復發性卵巢癌的二期手術細胞減少術。
PaulinoE.
N EnglJ Med. 2020 Feb 13;382(7):685-686.
7.
SecondarySurgical Cytoreduction for Recurrent Ovarian Cancer.
復發性卵巢癌的二期手術細胞減少術。
SharmaV, Naik RD, Vanidassane I.
N EnglJ Med. 2020 Feb 13;382(7):685.
8.
TripleTherapy for Cystic Fibrosis with a Phe508del CFTR Mutation. Reply.
Phe508delCFTR突變的囊性纖維化三重治療。回復。
JainR, Middleton PG, Rowe SM.
N EnglJ Med. 2020 Feb 13;382(7):684.
9.
TripleTherapy for Cystic Fibrosis with a Phe508del CFTR Mutation.
Phe508delCFTR突變的囊性纖維化三重治療。
McGarryME.
N EnglJ Med. 2020 Feb 13;382(7):684.
10.
Eliminationof the Autopsy Requirement by CMS.
CMS排除屍檢要求。
RueckertJ.
N EnglJ Med. 2020 Feb 13;382(7):683-684.
11.
UnfoldingDiscoveries in Heart Failure.
心臟衰竭的新發現。
PaulusWJ.
N EnglJ Med. 2020 Feb 13;382(7):679-682.
12.
TheMagic of Randomization versus the Myth of Real-World Evidence.
隨機化的魔力與真實世界證據的神話。
CollinsR, Bowman L, Landray M, Peto R.
N EnglJ Med. 2020 Feb 13;382(7):674-678.
13.
ANCA-AssociatedVasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids.
血漿置換和糖皮質激素治療ANCA相關性血管炎。
DerebailVK, Falk RJ.
N EnglJ Med. 2020 Feb 13;382(7):671-673.
14.
MajorStrides in HER2 Blockade for Metastatic Breast Cancer.
HER2阻斷治療轉移性乳腺癌的重大進展。
SharmaP.
N EnglJ Med. 2020 Feb 13;382(7):669-671.
15.
Case5-2020: A 32-Day-Old Male Infant with a Fall.
病例5-2020：一名32天大的男嬰跌倒。
NewtonAW, Caruso PA, Ebb DH, Linder G.
N EnglJ Med. 2020 Feb 13;382(7):656-664.
16.
Hung-upKnee Jerk in Huntington's Disease.
在亨廷頓氏病中下意識不安。
FukumotoT, Miyamoto R.
N EnglJ Med. 2020 Feb 13;382(7):e10.
17.
ASublingual Epidermoid Cyst.
舌下表皮樣囊腫。
ThibouwF, Schein A.
N EnglJ Med. 2020 Feb 13;382(7):655.
18.
Milkand Health.
牛奶和健康。
WillettWC, Ludwig DS.
N EnglJ Med. 2020 Feb 13;382(7):644-654.
19.
Outbreakof Listeriosis in South Africa Associated with Processed Meat.
南非與加工肉相關的李斯特菌病暴發。
ThomasJ, Govender N, McCarthy KM, Erasmus LK, Doyle TJ, Allam M, Ismail A, Ramalwa N,Sekwadi P, Ntshoe G, Shonhiwa A, Essel V, Tau N, Smouse S, Ngomane HM,Disenyeng B, Page NA, Govender NP, Duse AG, Stewart R, Thomas T, Mahoney D,Tourdjman M, Disson O, Thouvenot P, Maury MM, Leclercq A, Lecuit M, Smith AM,Blumberg LH.
N EnglJ Med. 2020 Feb 13;382(7):632-643.
20.
PlasmaExchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
嚴重ANCA相關性血管炎的血漿交換和糖皮質激素。
WalshM, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, Hawley CM, Khalidi N,Floßmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF,Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W,Flores-Suárez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B,Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW;PEXIVAS Investigators.
N EnglJ Med. 2020 Feb 13;382(7):622-631.
21.
OnSuboptimization - Cadillac Care at the Mecca.
關於次優化-麥加的凱迪拉克護理。
ReillyBM.
N EnglJ Med. 2020 Feb 13;382(7):593-595.
22.
ModernizingScope-of-Practice Regulations - Time to Prioritize Patients.
現代化的實踐範圍規定-時間優先考慮病人。
FrognerBK, Fraher EP, Spetz J, Pittman P, Moore J, Beck AJ, Armstrong D, Buerhaus PI.
N EnglJ Med. 2020 Feb 13;382(7):591-593.
23.
TheClimate Crisis and Clinical Practice.
氣候危機與臨床實踐。
SalasRN.
N EnglJ Med. 2020 Feb 13;382(7):589-591.
24.
ADisclosure Form for Work Submitted to Medical Journals - A Proposal from theInternational Committee of Medical Journal Editors.
向醫學期刊提交的工作披露表-國際醫學期刊編輯委員會的建議。
TaichmanDB, Backus J, Baethge C, Bauchner H, Flanagin A, Florenzano F, Frizelle FA,Godlee F, Gollogly L, Haileamlak A, Hong ST, Horton R, James A, Laine C, MillerPW, Pinborg A, Rubin EJ, Sahni P.
N EnglJ Med. 2020 Feb 13;382(7):667-668.
25.
Tucatinib,Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Tucatinib、曲妥珠單抗和卡培他濱治療HER2陽性轉移性乳腺癌。
MurthyRK, Loi S, Okines A, Paplomata E, Hamilton E, Hurvitz SA, Lin NU, Borges V,Abramson V, Anders C, Bedard PL, Oliveira M, Jakobsen E, Bachelot T, ShacharSS, Müller V, Braga S, Duhoux FP, Greil R, Cameron D, Carey LA, Curigliano G,Gelmon K, Hortobagyi G, Krop I, Loibl S, Pegram M, Slamon D, Palanca-WesselsMC, Walker L, Feng W, Winer EP.
N EnglJ Med. 2020 Feb 13;382(7):597-609.
26.
TrastuzumabDeruxtecan in Previously Treated HER2-Positive Breast Cancer.
曲妥珠單抗滅活素治療HER2陽性乳腺癌的療效觀察。
ModiS, Saura C, Yamashita T, Park YH, Kim SB, Tamura K, Andre F, Iwata H, Ito Y,Tsurutani J, Sohn J, Denduluri N, Perrin C, Aogi K, Tokunaga E, Im SA, Lee KS,Hurvitz SA, Cortes J, Lee C, Chen S, Zhang L, Shahidi J, Yver A, Krop I;DESTINY-Breast01 Investigators.
N EnglJ Med. 2020 Feb 13;382(7):610-621.
N Engl J Med[Jour]AND 382 [volume] AND 8[issue]
新英格蘭醫學雜誌 382卷8期
1．
Emicizumabin Hemophilia A. Reply.
血友病A。回答。
AledortLM.
N EnglJ Med. 2020 Feb 20;382(8):786.
2.
Emicizumabin Hemophilia A.
血友病A。
BucknerTW, Watson C, Recht M.
N EnglJ Med. 2020 Feb 20;382(8):785-786.
3.
Emicizumabin Hemophilia A.
血友病A。
Kruse-JarresR, Hay CRM.
N EnglJ Med. 2020 Feb 20;382(8):785.
4.
AcuteUpper Airway Obstruction. Reply.
急性上呼吸道阻塞。回復。
EskanderA, de Almeida JR, Irish JC.
N EnglJ Med. 2020 Feb 20;382(8):784.
5.
AcuteUpper Airway Obstruction.
急性上呼吸道阻塞。
LamaTT, Berra L.
N EnglJ Med. 2020 Feb 20;382(8):783-784.
6.
AcuteUpper Airway Obstruction.
急性上呼吸道阻塞。
ThilenS, Bowdle A.
N EnglJ Med. 2020 Feb 20;382(8):783.
7.
AcuteUpper Airway Obstruction.
急性上呼吸道阻塞。
CramerJD, Brenner MJ, Feller-Kopman D.
N EnglJ Med. 2020 Feb 20;382(8):783.
8.
AcuteUpper Airway Obstruction.
急性上呼吸道阻塞。
CannonJW, Gurney JM, Shackelford SA.
N EnglJ Med. 2020 Feb 20;382(8):782-783.
9.
AcuteUpper Airway Obstruction.
急性上呼吸道阻塞。
SchechtmanSA, Healy DW, Abdelmalak B.
N EnglJ Med. 2020 Feb 20;382(8):782.
10.
Nintedanibin Progressive Fibrosing Interstitial Lung Diseases. Reply.
Nintedanib治療進行性纖維化間質性肺疾病。回復。
FlahertyKR, Wells AU, Brown KK.
N EnglJ Med. 2020 Feb 20;382(8):781.
11.
Nintedanibin Progressive Fibrosing Interstitial Lung Diseases.
Nintedanib治療進行性纖維化間質性肺疾病。
KaoJH, Huang HT, Li KJ.
N EnglJ Med. 2020 Feb 20;382(8):780-781.
12.
Nintedanibin Progressive Fibrosing Interstitial Lung Diseases.
Nintedanib治療進行性纖維化間質性肺疾病。
FabreA, Nicholson AG.
N EnglJ Med. 2020 Feb 20;382(8):780.
13.
Nintedanibin Progressive Fibrosing Interstitial Lung Diseases.
Nintedanib治療進行性纖維化間質性肺疾病。
RaghuG.
N EnglJ Med. 2020 Feb 20;382(8):779-780.
14.
BehavioralHeuristics in Coronary-Artery Bypass Graft Surgery.
行為啟發式在冠狀動脈搭橋術中的應用。
OlenskiAR, Zimerman A, Coussens S, Jena AB.
N EnglJ Med. 2020 Feb 20;382(8):778-779.
15.
Respondingto Unprofessional Behavior by Trainees - A "Just Culture" Framework.
對受訓者的不專業行為作出反應-一個「公正文化」框架。
WassermanJA, Redinger M, Gibb T.
N EnglJ Med. 2020 Feb 20;382(8):773-777.
16.
Disclosureof Genetic Risk Revealed in a Research Study.
一項研究揭示了遺傳風險。
CastellanosA, Phimister EG, Stefánsson K, Clayton EW.
N EnglJ Med. 2020 Feb 20;382(8):763-765.
17.
LowerBlood Pressure in South Asia? Trial Evidence.
南亞低血壓？審判證據。
PoulterN.
N EnglJ Med. 2020 Feb 20;382(8):758-760.
18.
Breakingthe Itch-Scratch Cycle in Prurigo Nodularis.
打破結節性痒疹搔癢循環。
KwatraSG.
N EnglJ Med. 2020 Feb 20;382(8):757-758.
19.
Corneringthe Suspects in Vaping-Associated EVALI.
在Vaping聯合撤離行動中把嫌疑犯逼到牆角。
GordonT, Fine J.
N EnglJ Med. 2020 Feb 20;382(8):755-756.
20.
Case6-2020: A 34-Year-Old Woman with Hyperglycemia.
病例6-2020：一名34歲的高血糖婦女。
UdlerMS, Powe CE, Austin-Tse CA.
N EnglJ Med. 2020 Feb 20;382(8):745-753.
21.
IntestinalLipomatosis.
腸脂肪瘤病。
MansoorMS, Batool A.
N EnglJ Med. 2020 Feb 20;382(8):e12.
22.
SarcoidalReaction in a Tattoo.
紋身上的肌肉反應。
Lim D,Nantel-Battista M.
N EnglJ Med. 2020 Feb 20;382(8):744.
23.
Preventionof Falls in Community-Dwelling Older Adults.
社區老年人跌倒的預防。
GanzDA, Latham NK.
N EnglJ Med. 2020 Feb 20;382(8):734-743.
24.
ACommunity-Based Intervention for Managing Hypertension in Rural South Asia.
南亞農村高血壓管理的社區幹預。
JafarTH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL,Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L;COBRA-BPS Study Group.
N EnglJ Med. 2020 Feb 20;382(8):717-726.
25.
Trialof Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
尼莫留單抗治療中重度結節性痒疹的臨床研究。
StänderS, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, Bieber T, Misery L,Wollenberg A, Reich A, Ahmad F, Piketty C.
N EnglJ Med. 2020 Feb 20;382(8):706-716.
26.
WhenSensitivity Is a Liability.
當敏感是一種責任時。
BaruchJ.
N EnglJ Med. 2020 Feb 20;382(8):694-695.
27.
Retraction:Banegas JR et al. Relationship between Clinic and Ambulatory Blood-PressureMeasurements and Mortality. N Engl J Med 2018;378:1509-20.
收回：BanegasJR等人。臨床和動態血壓測量與死亡率的關係。英國醫學雜誌2018；378:1509-20。
BanegasJR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ,Ruiz-Hurtado G, Segura J, Rodríguez-Artalejo F, Williams B.
N EnglJ Med. 2020 Feb 20;382(8):786.
28.
ANovel Coronavirus from Patients with Pneumonia in China, 2019.
來自中國肺炎患者的新型冠狀病毒，2019年。
Zhu N,Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P,Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel CoronavirusInvestigating and Research Team.
N EnglJ Med. 2020 Feb 20;382(8):727-733.
29.
AnotherDecade, Another Coronavirus.
又一個十年，又一個冠狀病毒。
PerlmanS.
N EnglJ Med. 2020 Feb 20;382(8):760-762.
30.
ANovel Coronavirus Emerging in China - Key Questions for Impact Assessment.
中國新出現的冠狀病毒-影響評估的關鍵問題。
MunsterVJ, Koopmans M, van Doremalen N, van Riel D, de Wit E.
N EnglJ Med. 2020 Feb 20;382(8):692-694.
31.
TheEVALI and Youth Vaping Epidemics - Implications for Public Health.
EVALI和青年Vaping流行病-對公共衛生的影響。
KingBA, Jones CM, Baldwin GT, Briss PA.
N EnglJ Med. 2020 Feb 20;382(8):689-691.
32.
SyndromicSurveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
電子菸或Vaping、產品使用相關肺損傷的症候群監測。
HartnettKP, Kite-Powell A, Patel MT, Haag BL, Sheppard MJ, Dias TP, King BA, MelstromPC, Ritchey MD, Stein Z, Idaikkadar N, Vivolo-Kantor AM, Rose DA, Briss PA,Layden JE, Rodgers L, Adjemian J.
N EnglJ Med. 2020 Feb 20;382(8):766-772.
33.
VitaminE Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI.
與EVALI相關的支氣管肺泡灌洗液中的維生素E醋酸鹽。
BlountBC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M,Braselton M, Brosius CR, Caron KT, Chambers D, Corstvet J, Cowan E, De JesúsVR, Espinosa P, Fernandez C, Holder C, Kuklenyik Z, Kusovschi JD, Newman C,Reis GB, Rees J, Reese C, Silva L, Seyler T, Song MA, Sosnoff C, Spitzer CR,Tevis D, Wang L, Watson C, Wewers MD, Xia B, Heitkemper DT, Ghinai I, Layden J,Briss P, King BA, Delaney LJ, Jones CM, Baldwin GT, Patel A, Meaney-Delman D,Rose D, Krishnasamy V, Barr JR, Thomas J, Pirkle JL; Lung Injury ResponseLaboratory Working Group.
N EnglJ Med. 2020 Feb 20;382(8):697-705.
N Engl J Med[Jour]AND 382 [volume] AND 9[issue]
新英格蘭醫學雜誌 382卷9期
1.
AudioInterview: Preparing for the Spread of Covid-19.
音頻採訪：準備傳播Covid-19。
RubinEJ, Baden LR, Morrissey S.
N EnglJ Med. 2020 Feb 27;382(9):e18.
2.
Medicineand the Mind. Reply.
醫學和思想。回復。
GardnerC, Kleinman A.
N EnglJ Med. 2020 Feb 27;382(9):880.
3.
Medicineand the Mind.
醫學和思想。
NeimarkG.
N EnglJ Med. 2020 Feb 27;382(9):879-880.
4.
Medicineand the Mind.
醫學和思想。
LiebermanJA, Dosovitz SM.
N EnglJ Med. 2020 Feb 27;382(9):879.
5.
Medicineand the Mind.
醫學和思想。
GordonJA.
N EnglJ Med. 2020 Feb 27;382(9):878-879.
6.
Encorafenib,Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. Reply.
BRAFV600E突變結直腸癌中的安可拉非尼、比尼黴素和西妥昔單抗。回復。
KopetzS, Grothey A, Tabernero J.
N EnglJ Med. 2020 Feb 27;382(9):877-878.
7.
Encorafenib,Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
BRAFV600E突變結直腸癌中的安可拉非尼、比尼黴素和西妥昔單抗。
PietrantonioF.
N EnglJ Med. 2020 Feb 27;382(9):876-877.
8.
Encorafenib,Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
BRAFV600E突變結直腸癌中的安可拉非尼、比尼黴素和西妥昔單抗。
PrasadV.
N EnglJ Med. 2020 Feb 27;382(9):876.
9.
Encorafenib,Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.
BRAFV600E突變結直腸癌中的安可拉非尼、比尼黴素和西妥昔單抗。
SharmaV, Vanidassane I.
N EnglJ Med. 2020 Feb 27;382(9):876.
10.
Nivolumabplus Ipilimumab in Non-Small-Cell Lung Cancer. Reply.
Nivolumab聯合伊普利單抗治療非小細胞肺癌。回復
HellmannMD, Ramalingam SS.
N EnglJ Med. 2020 Feb 27;382(9):875.
11.
Nivolumabplus Ipilimumab in Non-Small-Cell Lung Cancer.
Nivolumab聯合伊普利單抗治療非小細胞肺癌。
BersanelliM, Tiseo M, Banna GL.
N EnglJ Med. 2020 Feb 27;382(9):874-875.
12.
Nivolumabplus Ipilimumab in Non-Small-Cell Lung Cancer.
Nivolumab聯合伊普利單抗治療非小細胞肺癌。
Kim J,Shin SW.
N EnglJ Med. 2020 Feb 27;382(9):874.
13.
TumorMicroenvironment, Metabolism, and Immunotherapy.
腫瘤微環境、代謝與免疫治療。
DeBerardinisRJ.
N EnglJ Med. 2020 Feb 27;382(9):869-871.
14.
TAVRat 5 Years - Rematch or Swan Song for Surgery?
5年後的TAVR-重賽還是手術的天鵝之歌？
VanBelle E.
N EnglJ Med. 2020 Feb 27;382(9):867-868.
15.
Case7-2020: A 52-Year-Old Man with a Mass in the Left Breast.
病例7-2020：一名52歲男性，左乳房腫塊。
IsakoffSJ, Lehman CD, Shannon KM, Basnet KM.
N EnglJ Med. 2020 Feb 27;382(9):856-864.
16.
BiliaryCast Syndrome.
膽道鑄型症候群。
WangK, Wu S.
N EnglJ Med. 2020 Feb 27;382(9):e13.
17.
AngiosarcomaInvolving the Heart.
累及心臟的血管肉瘤。
PazhenkottilAP, Bode PK.
N EnglJ Med. 2020 Feb 27;382(9):855.
18.
TheModern Epidemic of Syphilis.
現代流行的梅毒。
GhanemKG, Ram S, Rice PA.
N EnglJ Med. 2020 Feb 27;382(9):845-854.
19.
Effectsof Germline VHL Deficiency on Growth, Metabolism, and Mitochondria.
生殖系VHL缺乏對生長、代謝和線粒體的影響。
PerrottaS, Roberti D, Bencivenga D, Corsetto P, O'Brien KA, Caiazza M, Stampone E,Allison L, Fleck RA, Scianguetta S, Tartaglione I, Robbins PA, Casale M, WestJA, Franzini-Armstrong C, Griffin JL, Rizzo AM, Sinisi AA, Murray AJ, BorrielloA, Formenti F, Della Ragione F.
N EnglJ Med. 2020 Feb 27;382(9):835-844.
20.
Microbiotaas Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
微生物群作為異基因造血細胞移植死亡率的預測因子。
PeledJU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D,Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK,Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, RomeroK, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ,Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A,Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K,Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR,Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM.
N EnglJ Med. 2020 Feb 27;382(9):822-834.
21.
Pembrolizumabfor Early Triple-Negative Breast Cancer.
彭布羅利珠單抗治療早期三陰性乳腺癌。
SchmidP, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, HuiR, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L,Karantza V, Zhao J, Aktan G, Dent R, O'Shaughnessy J; KEYNOTE-522Investigators.
N EnglJ Med. 2020 Feb 27;382(9):810-821.
22.
Is HeOK?
他沒事吧？
AndristE.
N EnglJ Med. 2020 Feb 27;382(9):795-797.
23.
TransformingGlobal Health with AI.
用人工智慧改變全球健康。
MehtaMC, Katz IT, Jha AK.
N EnglJ Med. 2020 Feb 27;382(9):791-793.
24.
OrganDonation after Medical Assistance in Dying - Canada's First Cases.
臨終醫療救助後器官捐獻——加拿大首例。
[Noauthors listed]
N EnglJ Med. 2020 Feb 27;382(9):881.
25.
Five-YearOutcomes of Transcatheter or Surgical Aortic-Valve Replacement.
經導管或外科主動脈瓣置換術的5年預後。
MakkarRR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, Yoon SH, Trento A,Svensson LG, Herrmann HC, Szeto WY, Miller DC, Satler L, Cohen DJ, Dewey TM, BabaliarosV, Williams MR, Kereiakes DJ, Zajarias A, Greason KL, Whisenant BK, Hodson RW,Brown DL, Fearon WF, Russo MJ, Pibarot P, Hahn RT, Jaber WA, Rogers E, Xu K,Wheeler J, Alu MC, Smith CR, Leon MB; PARTNER 2 Investigators.
N EnglJ Med. 2020 Jan 29;382(9):799-809.
26.
Influenzain U.S. Detention Centers - The Desperate Need for Immunization.
美國拘留中心的流感-迫切需要免疫接種。
FoppianoPalacios C, Openshaw JJ, Travassos MA.
N EnglJ Med. 2020 Feb 27;382(9):789-791.
27.
Importationand Human-to-Human Transmission of a Novel Coronavirus in Vietnam.
一種新型冠狀病毒在越南的輸入和人與人之間的傳播。
PhanLT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, Nguyen TT, Cao TM, PhamQD.
N EnglJ Med. 2020 Feb 27;382(9):872-874.
28.
MedicalJournals and the 2019-nCoV Outbreak.
醫學期刊和2019年nCoV爆發。
RubinEJ, Baden LR, Morrissey S, Campion EW.
N EnglJ Med. 2020 Feb 27;382(9):866.
29.
UnethicalInternational Nurse-Staffing Agencies - The Need for Legislative Action.
不道德的國際護士人員配置機構-立法行動的必要性。
PittmanP, Pulver AR.
N EnglJ Med. 2020 Feb 27;382(9):793-795.